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Abstract:  Advances in optical imaging modalities, such as optical 
coherence tomography (OCT), enable us to observe tissue microstructure at 
high resolution and in real time. Currently, core-needle biopsies are guided 
by external imaging modalities such as ultrasound imaging and x-ray 
computed tomography (CT) for breast and lung masses, respectively. These 
image-guided procedures are frequently limited by spatial resolution when 
using ultrasound imaging, or by temporal resolution (rapid real-time 
feedback capabilities) when using x-ray CT. One feasible approach is to 
perform OCT within small gauge needles to optically image tissue 
microstructure. However, to date, no system or core-needle device has been 
developed that incorporates both three-dimensional OCT imaging and tissue 
biopsy within the same needle for true OCT-guided core-needle biopsy. We 
have developed and demonstrate an integrated core-needle biopsy system 
that utilizes catheter-based 3-D OCT for real-time image-guidance for target 
tissue localization, imaging of tissue immediately prior to physical biopsy, 
and subsequent OCT imaging of the biopsied specimen for immediate 
assessment at the point-of-care. OCT images of biopsied ex vivo  tumor 
specimens acquired during core-needle placement are correlated with 
corresponding histology, and computational visualization of arbitrary planes 
within the 3-D OCT volumes enables feedback on specimen tissue type and 
biopsy quality. These results demonstrate the potential for using real-time 3-
D OCT for needle biopsy guidance by imaging within the needle and tissue 
during biopsy procedures. 
© 2012 Optical Society of America 
OCIS codes:  (170.4500) Optical coherence tomography; (120.3890) Medical optics 
instrumentation; (110.6880) Three-dimensional image acquisition; (170.1610) Clinical 
applications. 
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1. Introduction 
Cell or tissue specimens are needed for the pathological diagnosis of disease. Clinical imaging 
modalities such as magnetic resonance imaging (MRI), computed tomography (CT), 
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(C) 2012 OSA 1 June 2012 / Vol. 3,  No. 6 / BIOMEDICAL OPTICS EXPRESS  1150ultrasound imaging, and planar x-ray are standard non-invasive technologies used for 
screening or identifying abnormal masses. Obtaining cell or tissue specimens for pathological 
diagnosis, however, often requires fine-needle or core-needle biopsy procedures, respectively, 
to extract specimens from patients. For example, fine-needle biopsies are performed on 
thyroid masses detected on physical examination or ultrasound imaging, and collections of 
needle-aspirated cells are viewed by cytopathologists. Core-needle biopsies (CNBs), which 
extract larger tissue cores to maintain tissue architecture, are frequently guided by ultrasound 
imaging, stereotactic x-ray imaging, or MRI and used in evaluating breast masses found on x-
ray or MR mammography. Lung nodules found on planar chest x-ray images are often 
biopsied with core-needles under x-ray CT guidance. 
Many studies have shown that MRI significantly improves the screening in women 
susceptible to breast cancer, and the use of MRI in breast imaging is rapidly expanding. This 
success can be attributed to the capability of MRI to resolve and identify small lesions or 
micro-calcifications. The sensitivity of MRI (71.1%) was found to be much higher than that of 
x-ray mammography (40%) [1]. In this study, MRI detected 20 cancers that were missed by x-
ray mammography or clinical breast examination among 45 cancers in total. More than half of 
these invasive tumors were smaller than 10 mm [1]. Despite its high sensitivity, the specificity 
of MRI screening is not satisfactory, generally around 68% [2]. Early detection of suspicious 
lesions by MRI or other non-invasive imaging techniques has placed an increased demand on 
accurately localizing biopsy needles to these small lesions, particularly for percutaneous CNB 
procedures [3]. 
The current diagnostic efficacy of CNB is therefore problematic. In addition to high rates 
of underestimating high-risk and ductal carcinoma [4], large core-needle biopsy (LCNB) 
shows a relatively high miss rate. The miss rates for various diagnostic strategies differ, but 
include: 2% for needle-localized breast open biopsy (NLBB), 12% for LCNB, 3% for LCNB 
in a study setting, and 5% for fine needle aspiration [4]. For an 18-gauge needle with 2 or 3 
passes, stereotactic-guided LCNB has a disappointing 66.6% miss rate [4]. Today, physicians 
often take 6 or more cores in one lesion in an effort to reduce this miss rate and obtain a 
sufficient amount of tissue for diagnosis [4,5]. Similar results were presented by another study 
in which 16% of the subjects underwent repeat biopsy procedures, and among them, 39% had 
malignancies [6]. The  sensitivity of CNB depends considerably on the properties of the 
lesions, the experience of the physicians and technicians, and the performance characteristics 
of the biopsy machines [3,4]. Regardless, there is a strong need to improve the technology and 
methodology to more accurately identify and localize increasingly smaller lesions, to provide 
real-time image-guidance within the needle itself and during the biopsy, and to image the 
biopsied specimens with high-resolution at the point-of-care so that the  physician can 
determine if the target abnormal lesion has been appropriately biopsied prior to ending the 
procedures and sending the tissue specimens for sectioning, staining, and histopathological 
analysis. 
Optical coherence tomography (OCT) has emerged as a fast high-resolution 3-D 
biomedical imaging modality that can be used to identify pathological tissues including many 
types of cancers in the breast, lung, thyroid, kidney, liver, and brain, among many others [7–
11]. With axial-scan line rates of tens to hundreds of thousands of Hertz, imaging resolution 
of 2-10 microns, and imaging depth of 1-2 mm in highly scattering media, OCT is a suitable 
candidate for real-time 3-D assessment of biological tissue [12]. Moreover, computational 
algorithms are being developed to rapidly perform computer-aided detection, such as in breast 
tissue [13–15]. The miniaturization of OCT beam-delivery optics to a few hundreds of 
microns [16,17] permits integration of sample-arm fibers and micro-optics within fine- and 
core-needle biopsy needles to provide minimally-invasive imaging within soft tissues or 
suspicious lesions. Numerous groups have demonstrated the use of optical needles for OCT 
imaging and diagnostics [18–25]. However, these optical needles typically consist of a single 
optical fiber and micro-optics within a single metal needle barrel, and require that the OCT 
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physically biopsy tissue and retrieve tissue specimens. To date, there has been no 
demonstration of an OCT-guided needle-biopsy device or system that permits physical tissue 
biopsy immediately after OCT guided placement and lesion localization, and no optical needle 
system has been demonstrated that enables 3-D OCT imaging  of the physically biopsied 
specimen to assess the quality of the biopsied specimen prior to sending to the pathology 
department for histopathological processing and evaluation. 
In this paper, we introduce the design, development, and demonstration of a 3-D OCT-
guided core-needle biopsy system that permits the real-time OCT-guided positioning of the 
biopsy needle, 3-D OCT of tissue regions immediately prior to tissue biopsy, and subsequent 
3-D OCT of the biopsied specimen to visualize and confirm if abnormal lesion tissue was 
adequately sampled prior to histopathological analysis. Our integrated system design includes 
a re-designed and engineered hand-held core-needle biopsy device that leverages the 
advanced development of both a commercial vacuum-assisted  core-needle breast biopsy 
system (Hologic, Inc.) and a commercial catheter-based 3-D OCT system (St. Jude Medical, 
Inc.) to permit real-time OCT guidance during use. We believe this system and methodology 
offers the best opportunity to reduce non-diagnostic sampling rates for small non-palpable 
lesions, to reduce the number of tissue biopsy cores necessary to adequately sample the lesion 
and surrounding tissue, and to potentially alleviate differences in non-diagnostic sampling 
rates between experienced and inexperienced physicians due to the fact that with this method, 
we are able to accurately select regions of interest while the needle is still in the tissue. 
2. Materials and methods 
The integrated system developed for these studies consisted of three components: 1) a 
modified core-needle biopsy hand-piece, 2) a vacuum-assisted breast needle biopsy console 
(Suros, model ATEC Pearl Breast Biopsy System, Hologic, Inc.), and 3) a catheter-based 
OCT system (Model C7XR, St. Jude Medical, Inc.) (Fig. 1). 
 
Fig. 1. Overview of the 3-D OCT-guided vacuum-assisted core-needle breast biopsy system. 
This integrated system was designed to leverage the advantages of commercial systems, 
yet develop a new design and concept for a core-needle biopsy hand-piece that can be 
optically-guided in real-time by OCT. For guidance during needle insertion, positioning, and 
biopsy, and to acquire a 3-D OCT image of the biopsied specimen to provide a microscopic 
“first look” of the specimen prior to sending for histopathological sectioning and analysis, the 
OCT catheter is inserted into the needle-biopsy hand-piece which has been modified to 
include optical windows at specific locations. The design and methodology presented here 
maintains the full functionality of the vacuum-assisted core-needle breast biopsy system as 
well as the catheter-based OCT system. 
2.1. OCT-guided vacuum-assisted core-needle biopsy hand-piece 
The standard vacuum-assisted core-needle biopsy hand-piece mechanically operates via 
pneumatic pressure and vacuum (Fig. 2). When attached to the system console and armed, a 
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smooth outer needle barrel prior to insertion into tissue. When the needle tip has been 
positioned at the tissue site for biopsy (typically guided under external imaging by stereotactic 
x-ray or ultrasound imaging), a foot pedal switch initiates a vacuum to draw the cutting 
cannula back, thereby exposing the biopsy channel, and allowing a small region of tissue to be 
drawn under vacuum into the biopsy channel region. We modified the biopsy extraction 
sequence by putting a manual break between the opening of the cutting cannula with the 
applied vacuum, and the closing of cutting cannula. Following another activation switch, the 
outer cutting cannula closes with a rotating/spinning motion and shears off the tissue 
specimen. We also included a second manual break in the process, before the tissue is 
subsequently drawn back into a tissue collection trap by the applied vacuum where it can be 
later retrieved and placed in formalin for histopathological processing. 
 
Fig. 2. Schematics and photograph of the modified vacuum-assisted core-needle biopsy hand-
piece for 3-D OCT-guided procedures. (A) Schematic of original hand-piece components. 
Using pressure and vacuum, the unit mechanically opens and closes a cutting cannula, and 
vacuum is used to both draw tissue into the biopsy channel prior to biopsy, and to draw 
biopsied tissue back into a tissue trap for retrieval. (B) Schematic of modified hand-piece, 
which includes the addition of a transparent front window for real-time OCT guidance, the 
addition of a long steel/plastic tube through which the OCT catheter is inserted, and a Y-valve 
to allow both linear access for the OCT catheter and the vacuum/pressure tube connection. (C) 
Photograph of modified hand-piece. 
Numerous essential modifications were made to the biopsy hand-piece (ATEC 0912-20, 9 
Gauge) to enable real-time 3-D OCT guidance (Fig. 2). First, an optical window was added at 
the distal tip of the 12 cm-long 9 Gauge core-biopsy needle by removing a portion of the 
metal needle barrel to lengthen the tissue biopsy channel by 7.6 mm. In addition, the cutting 
cannula was also shortened by 8.6 mm to preserve the cutting/biopsy function of the device, 
while providing an optical window for OCT imaging. A transparent hemi-cylindrical Pyrex 
glass segment was used in place of the removed metal barrel segment. Second, a 50 cm-long 
metal tube (1.6 mm outer diameter) with a transparent plastic tube (1.5 mm outer diameter) 
attached to the distal end was fabricated and inserted into the hand-piece, running the entire 
length up to the front window region, and located within the metal needle barrel. Given the 
1.5 mm outer diameter of the plastic tube, and the 3.0 mm inner diameter of the metal needle 
barrel, the added plastic tube filled 25% of the cross-sectional area of the needle barrel, 
resulting in a similar reduction in the cross-sectional area available for the biopsied tissue 
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large-bore hollow central tube through which biopsied tissue is drawn via vacuum into a 
proximal tissue collection chamber or trap. This hollow central tube provided ready access for 
an OCT catheter (Fig. 3). The distal transparent plastic tube was positioned to span the tissue 
biopsy channel and extend up to where the front window was located. This tube enabled 3-D 
OCT imaging of the tissue (in a cylindrical wedge-shaped volume) during needle positioning, 
and both immediately prior to biopsy and following biopsy when the cutting cannula had 
closed and while the biopsied tissue specimen remained in the biopsy channel. Third, the  
 
Fig. 3. Modified hand-piece tip detail. (A) Schematic of the modifications made to the core-
needle tip including lengthening of the biopsy channel to accommodate a front window, and 
the addition of a transparent tube (attached to the distal end of the added metal tube) through 
which the OCT catheter is passed for imaging. (B) Photograph of modified tip with the cutting 
cannula retracted to expose the tissue biopsy channel. The plastic tube can be observed in the 
tissue biopsy channel, with its end opening into the front window region (parallel black lines 
and red box are added to highlight the OCT catheter tip location when fully inserted into the 
needle). (C) High-magnification photograph of the distal end of the OCT catheter. This 
catheter, with its own transparent outer sheath, is positioned either in the front window region 
or within the tissue biopsy channel for imaging. The scale bar refers only to the photograph in 
(C). The possible OCT scan volumes during needle tip guidance and during pre- and post-
biopsy are shown in (A). Only a cylindrical wedge of 3-D OCT data is possible due to a portion 
of the radial image being obscured by the metal needle barrel. However, additional 3-D OCT 
data from other wedge sections can be obtained by rotating the needle about its long axis. 
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addition of a Y-connector to allow for the straight passage of the long metal tube and insertion 
place for the OCT catheter. The modified tissue trap was sealed, and epoxy glue was also 
applied immediately proximal to the front window to hold a vacuum. The vacuum hose from 
the biopsy system console was attached to the other port of the Y-connector (Fig. 2). 
‘2.2. OCT-guided vacuum-assisted core-needle biopsy procedure 
The expected operation and use of this 3-D OCT image-guided needle biopsy system is 
summarized. Before inserting the needle into tissue, the system is initiated by closing the front 
aperture over the tissue biopsy chamber and starting the vacuum in the inner bore of the 
cannula, preparing the system for biopsy mode. It is important that the aperture of this biopsy 
chamber be closed prior to insertion and advancement into tissue to minimize tissue injury. 
The OCT catheter (Dragonfly model C7, St. Jude Medical, Inc.) is then inserted into the 
proximal end of the hand-piece via the small metal/plastic tube. The OCT catheter is first 
advanced within the hand-piece all the way until the catheter tip reaches the tip of the needle, 
making OCT imaging possible through the transparent front window. Under real-time OCT 
guidance (typically with high-speed rotational imaging at one fixed position without 
automated pull-back), the needle is inserted into tissue toward its target, relying on the radial 
OCT image data to provide immediate feedback and to differentiate normal from abnormal 
regions of tissue. 
Once the needle tip has been guided to and is located within the target tissue site, the 
needle is then advanced forward by ~1 cm to bring the target tissue into position over the 
tissue biopsy channel. The OCT catheter can then either be retracted by ~1 cm to position the 
imaging volume within the transparent tube segment located along the bottom of the tissue 
biopsy channel, or under system control, the catheter fiber/micro-optics can be pulled back 
within the stationary catheter sheath so that the 3-D OCT data collection occurs in the region 
of the biopsy channel. Next, following foot pedal activation, the inner cannula retracts, 
exposing the tissue biopsy channel and allowing the vacuum to draw the adjacent tissue of 
interest into the chamber prior to biopsy. The vacuum also serves to draw the tissue of interest 
in and around the plastic tube containing the OCT catheter, bringing the tissue within the 
optical depth-of-field of the catheter. At this time, 3-D OCT volumes with automated pull-
back can be collected to confirm the target tissue first visualized through the front window 
during needle placement. The needle can also be rotated or re-positioned (with or without 
vacuum) over small distances with the biopsy channel open and during OCT imaging to 
further validate the tissue site prior to physical biopsy. Once confirmed and following 
activation, the cutting cannula advances forward at high speed in a helical spinning pattern to 
cut the tissue located within the chamber. After the cutting cannula has closed the biopsy 
channel and has retained the biopsy specimen, additional 3-D OCT of the biopsied tissue can 
be performed to assess the specimen at the point-of-care, and prior to being sent to pathology 
for histological processing. The biopsied tissue specimen remains in the biopsy chamber until 
the vacuum generated by the console draws the tissue specimen through the hand-piece 
toward the proximal end where it comes to rest in the tissue trap and is later removed, placed 
in a fixative, and sent for histopathological processing and analysis. 
2.3. OCT system and imaging parameters 
The commercial OCT catheter (C7 Dragonfly Intravascular Imaging Catheter, St. Jude 
Medical, Inc.) used in this study was 1.35 m long, had an outer diameter of 0.9 mm, a 4.83 
mm imaging depth range, and specified axial and transverse resolutions of 20 µm and 25-60 
µm, respectively. Imaging was performed at an axial scan rate of 50 kHz, with either 
stationary (no pull-back) radial imaging up to 100 frames per second, or variable pull-back 
distances of 0-54 mm over 0-5 s. When performing stationary radial imaging, the system 
acquired 4032 radial A-scans per radial image. However, when performing radial imaging 
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radial A-scans per radial image were acquired, resulting in under-sampling of the tissue 
microstructure. Two-dimensional radial OCT images or 3-D cylindrical OCT volumes of data 
were exported from the system in tiff format, and additional 3-D volume rendering, 
visualization, and computational sectioning at en face and cross-sectional planes was done 
using commercial software (Amira, Inc.). 
To determine the effects of the front window and transparent plastic tube on the OCT 
imaging resolution, a 3-D tissue phantom was constructed using sub-resolution (<5 µm) point-
scatterers of TiO2 suspended in a polydimethylsiloxane (PDMS) medium (5 µg of TiO2 and 7 
g of PDMS). The 3-D tissue phantom was placed over the front window and open biopsy 
channel of the core-needle biopsy probe containing the OCT catheter, and OCT images were 
collected through the front window (operating in stationary radial imaging mode) as well as 
through the plastic tubing (operating in pull-back radial imaging mode). Measurements were 
made from the images of point-scatterers to determine the 3-D PSFs, corresponding to the 
axial and lateral resolutions (FWHM). The axial resolution of the beam passing through either 
the front window or the plastic tubing was measured to be 19 µm, which is consistent with the 
axial resolution from the catheter alone (20 µm). The lateral resolution of the beam passing 
through the front window was measured to be 24-26 µm, with no obvious asymmetry due to 
astigmatism from the curved glass window. The lateral resolution of the beam passing through 
the plastic tubing in the biopsy channel was measured to be 16-24 µm, however more accurate 
measurements were limited by the under-sampling of the image data during the automated 
pull-back sequence. These measured transverse resolution values are all consistent with those 
from the catheter alone (25-60 µm), with no obvious effects from astigmatism from the plastic 
tubing. 
2.4. Tissue specimens and histological processing 
To replicate the presence of abnormal tumor tissue within a larger mass of normal tissue, a 
~0.5 cm mass of lymphoid tissue with histologically-proven lymphoma from the thoracic 
cavity of a cat was wrapped with normal chicken breast tissue and inserted into a 50 ml, 
conical tube. These tissue types were chosen to present a  relatively challenging case for 
detecting subtle differences between two highly-scattering, relatively homogeneous-appearing 
tissue types under OCT. In addition, the needle-biopsy of lymph nodes and lymphoid tissue is 
a common medical procedure in the evaluation of potentially metastatic cancer. The needle 
was subsequently inserted into the tissue contained within the conical tube and under real-time 
OCT, guided to the tumor tissue site for physical biopsy. Multiple biopsy specimens were 
acquired, fixed in formalin, and processed, sectioned, and stained with hematoxylin and eosin 
for histological examination. Biopsy specimens were computationally sectioned both in cross-
section (corresponding to the orientation of radial OCT images) and in longitudinal 
orientation (corresponding to longitudinal B-mode OCT images) for co-registration and 
comparison with the acquired OCT images. 
3. Results 
3.1. Guiding window and real-time cross-sectional imaging 
Insertion and needle-tip placement was performed under real-time cross-sectional radial OCT 
imaging with the OCT catheter tip advanced all the way to the inner tip of the needle, where 
the OCT beam could pass out through the front window (Fig. 3). Representative image data 
and corresponding cross-sectional histology are shown in Fig. 4, along with a video (Media 
1). 
Figure 4(A) shows one radial OCT image that reveals the inner OCT catheter and its 
protective sheath, the transparent front window and the tissue located outside, and the highly 
scattering metal needle barrel. Note that at this front-window location, approximately 180°  
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Fig. 4. Real-time cross-sectional radial OCT-guided needle placement and biopsy. (A) Radial 
OCT image acquired by imaging through the transparent front window. Interfaces of the OCT 
catheter sheath, tissue, and metal needle barrel are evident. (B) Series of radial OCT images 
collected in real-time as the needle was advanced into tissue. Distance values are relative to the 
tissue surface. (C) Series of radial OCT images from a 3-D volume collected from a biopsied 
tissue specimen retained within the closed biopsy channel (as evident by the outer full-
circumference highly-scattering metal needle barrel). (D) Cross-sectional histology 
corresponding to the locations imaged in (C). The lymphoid tumor tissue is staining darker 
purple while the normal tissue is lighter pink. Included video (Media 1) of (B) was collected 
near the interface between the normal and tumor tissue. 
of the OCT radial scan is usable for tissue imaging with the other 180° obscured by the metal 
needle barrel. 
Figure 4(B) shows a sequence of 2-D radial OCT images at different positions as the 
needle was inserted into the tissue. Normal tissue is evident at the 2–6.5 cm positions. The 
denser more homogeneous lymphoid tumor tissue becomes apparent at the 7 cm position. 
From this series, needle barrel rotation is also observed as the needle was inserted into the 
tissue. Figure 4(C) shows a series of 2-D radial OCT images from a 3-D OCT volume of a 
tissue specimen after it has been physically biopsied and is being retained within the closed 
biopsy channel. Regions of normal and tumor tissue are observed. Note that the last two 
images in Fig. 4(C) show dark low-scattering regions corresponding to where there was an air 
space between the transparent tube and the inner wall of the needle barrel, while the other 
images show that the transparent tube had lifted away from the metal needle barrel, with 
tissue encircling the transparent tube while under vacuum. Corresponding cross-sectional 
histology sections are shown in Fig. 4(D), with each sectioned at the approximate location of 
the images shown in Fig. 4(C). 
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The needle geometry permits 3-D OCT data collection within the biopsy channel both before 
and after the physical biopsy has been taken. Imaging immediately prior to physical biopsy 
enables more precise positioning of the needle to biopsy the tissue of interest. The 3-D OCT 
data set is a cylindrical volume composed of both a cylindrical wedge of tissue data and the 
remaining data from the metal needle barrel. Computational sectioning of the 3-D data set 
permits visualization of the tissue in multiple ways. Figures 5 and 6 show longitudinal (along 
the long axis of the needle) en face and cross-sectional images extracted from the 3-D OCT 
data set, illustrating the multiple planes that can be extracted to visualize the tissue structure 
either before or immediately after the physical tissue biopsy. 
In this current design, the tissue drawn into the biopsy channel and around the OCT 
catheter is within the optical depth-of-field of the catheter. The transparent walls of the 
catheter sheath and plastic tube can be visualized in the 3-D reconstructions (Figs. 5(A) and 
6(A)), as well as the tissue located around the plastic tube. The images collected of the tissue 
show variations in scattering structures, with the lymphoid tumor tissue exhibiting a more 
homogeneous scattering pattern within the OCT images (Figs. 4(B,C) and 5(B,C)). The tissue 
regions imaged in Figs. 6(B) and 6(C), show more subtle variations in scattering due to the 
differences in cellular organization and tissue structure in the tumor regions versus areas of 
necrotic tissue, verified by the corresponding histology. The longitudinal images shown in 
Figs. 5 and 6 also exhibit lower lateral resolution and contrast due to the inherent under-
sampling of the automated pull-back imaging sequence, as described in the Materials and 
Methods. 
 
Fig. 5. Visualization of longitudinal (long-axis) en face planes of tissue data prior to tissue 
biopsy. (A) Three-dimensional renderings of the acquired OCT data set, illustrating orientation 
of en face planes relative to catheter and needle. (B) En face plane extracted at a plane that 
includes not only the tissue but also the transparent plastic tube and sheath housing the OCT 
catheter. (C) Enlarged region of imaged tissue, from the region indicated by the white dashed 
box in (B). 
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Fig. 6. Visualization of longitudinal (long-axis) cross-sectional planes of tissue data prior to 
and after tissue biopsy. (A) Three-dimensional renderings of the acquired OCT data set, 
illustrating orientation of cross-sectional planes relative to catheter and needle. (B) Cross-
sectional plane extracted before physical biopsy. (C) Cross-sectional plane of tissue specimen 
immediately after physical biopsy. (D) Corresponding histological section of physical biopsy 
specimen. Insets show magnified histology regions indicating areas of tumor and necrotic 
tissue. Orientation of histological specimen is approximately that shown in (B) and (C). 
4. Discussion 
There exists an urgent need for more precise positioning and real-time image guidance of 
needle biopsies. Our increasing ability to image and detect smaller abnormal masses and 
lesions using clinical modalities such as MRI, x-ray CT, PET/SPECT, and ultrasound imaging 
mandates that we also advance the technology to physically biopsy these smaller suspicious 
tissues. The result will be fewer non-diagnostic specimens and fewer subsequent surgical 
procedures that would  be required to access, remove, and histologically diagnose the 
suspicious lesions and masses found radiologically. 
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coarsely guide the placement of needle biopsies, such  as ultrasound, stereotactic x-ray 
imaging, or MRI guided breast needle biopsies, x-ray CT-guided needle biopsies for lung 
nodules and masses, or ultrasound-guided needle biopsies for thyroid nodules. However, most 
all of these are limited in their imaging  resolution (millimeters), have large instrument 
footprints (MRI, CT), require extended set-up preparation and use time (30-60 minutes), and 
cannot provide immediate feedback on the quality of the tissue specimen prior to sending it to 
pathology for histological processing and diagnostic assessment, which often occurs 12-24 
hours later. The compact 3-D OCT-guided core-needle biopsy system and methodology 
demonstrated here offers the potential to alleviate many of these practical limitations by 
providing fast, real-time optical image guidance of the actual needle tip and biopsy channel 
with micron-scale resolution, as well as the ability to image the tissue specimen immediately 
before and after the biopsy specimen has been collected, thereby providing a useful 3-D data 
set for evaluation, before the biopsy procedure ends, and before the specimens are sent off to 
the pathology department for standard histopathological processing and evaluation. 
There have been numerous prior studies demonstrating the design and use of an OCT 
imaging needle [15,18–25]. In all of these prior studies, however, no design facilitated the 
real-time imaging of the tissue immediately before and after physical biopsy. Rather, their 
practical use would require the removal of the OCT needle and cessation of imaging, followed 
by the placement of a second hollow needle used for acquiring the physical biopsy. In 
addition, no prior needle design would enable direct 3-D imaging of the biopsied specimen, 
without having to physically remove the specimen and mount it in an external OCT 
microscope-stage configuration. We believe the advantages of this core-needle design 
overcome many of these prior practical limitations. 
There are several limitations, however, that remain in this core-needle biopsy system that 
will need to be addressed for future clinical implementation. First, because of the wealth of 3-
D OCT data that is possible with this design, fast computational processing, sectioning, and 
visualization will be needed to facilitate the comprehensive point-of-care evaluation of the 
image data during the procedure. Fortunately, the rapid advances being made in the 
implementation of graphical processing units (GPUs) for OCT and other medical imaging 
modalities will make this functionality feasible [26,27]. Second, for this initial demonstration, 
the inner metal/plastic tube to protect the OCT catheter was inserted into and positioned 
adjacent to the inner wall of the collection tube within the commercial hand-piece. This tube 
occupied 25% of the inner cross-sectional area of the needle, thereby reducing the cross-
sectional area and volume of the biopsied tissue specimens. We do not believe, however, that 
this will significantly impact the quality of the tissue biopsy procedure, particularly since the 
added imaging capabilities are likely to improve tissue identification and biopsy, resulting in 
less tissue needed for biopsy. The additional metal/plastic tube, at times, restricted the 
vacuum-assisted transport of tissue specimens from the biopsy channel back to the tissue trap 
at the proximal end of the hand-piece. Future designs of this collection tube can be extruded to 
integrate the metal/plastic tube for the OCT catheter and minimize the crevasses where 
biopsied tissue specimens may get trapped and retained. Third, this prototype design utilized a 
relatively large gauge (9 Gauge) commercial biopsy needle. Future designs can reduce the 
diameter of the core-needle while still retaining the functional use of the OCT catheter. Future 
studies will demonstrate the use of this 3-D OCT-guided core-needle biopsy system in vivo in 
a large animal tumor model (porcine or canine) where the physical sizes of the body habitus 
and tumor tissue better approximate those found in humans. 
In conclusion, we have demonstrated a novel 3-D OCT vacuum-assisted core-needle 
biopsy system that enables for the first time the ability to image small (sub-millimeter) target 
tissue immediately before and after physical biopsy. In addition, optical windows in the 
modified core-needle hand-piece enable real-time OCT guidance of the needle tip during 
insertion and while positioning the needle prior to tissue biopsy. With advantages over many 
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methodology has the potential to improve our ability to biopsy the increasingly smaller lesions 
and masses now being identified by many clinical imaging systems. 
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